Associated Papers
Exploring gene editing as a potential therapeutic strategy for hemophilia.
Kumarasamy N et al.
Frontiers in Bioengineering and Biotechnology, 2026
CRISPR/Cas9-mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse.
Guan Y et al.
Embo Molecular Medicine, 2016
Select a paper to view details